Dementia with Lewy bodies

References

• Okazaki H, Lipkin L E, Aronson S M. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. Journal of Neuropathology and Experminental Neurology 1961; 20: 237–244
   PubMed Web of Science ®Google Scholar
• Kosaka K, Yosimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease?. Clinical Neuropathology 1984; 3: 185–192
   PubMed Web of Science ®Google Scholar
• Perry R H, Irving D, Blessed G, Perry E K, Fairbairn A F. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet 21 January, 1989; 1: 166
   PubMed Web of Science ®Google Scholar
• Lennox G, Lowe J, Landon M, Byrne E J, Mayer R J, Godwin-Austen R B. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. Journal of Neurology, Neurosurgery and Psychiatry 1989; 52: 236–1247
   PubMed Web of Science ®Google Scholar
• Dickson D W, Davies P, Mayeux R, et al. Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathologica (Berlin) 1986; 75: 8–15
   Web of Science ®Google Scholar
• Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1–8
   PubMed Web of Science ®Google Scholar
• Spillantini M G, Schmidt M L, Lee V MY, Trojanowski J Q, Jakes R, Goedert M. α-synuclein in Lewy bodies. Nature 1997; 388: 839–840
   PubMed Web of Science ®Google Scholar
• Trojanowski J Q. Dementia with Lewy bodies: Histopathological aspects of differential diagnosis. Neurobiology of Aging 1998; 4S: S4
   Google Scholar
• Lowe J S, Mayer R J, Landon M. Pathological significance of Lewy bodies in dementia. Dementia with Lewy bodies, R Perry, I McKeith, E Perry. Cambridge University Press, New York 1996; 195–203
   Google Scholar
• McKeith I G, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–1124
   PubMed Web of Science ®Google Scholar
• McKenzie J E, Edwards R J, Gentleman S M, Ince P G, Royston M C, Roberts G W. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of Lewy body type. Acta Neuropathologica 1996; 91: 526–529
   PubMed Web of Science ®Google Scholar
• Harrington C R, Perry R H, Perry E K, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994; 5: 215–228
   PubMedGoogle Scholar
• Hansen L A, Masliah E, Galasko D, Terry R D. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. Journal of Neuropathological and Experimental Neurology 1993; 52: 648–654
   PubMed Web of Science ®Google Scholar
• Perry R H, Irving D, Blessed G, Fairbairn A, Perry E K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of Neurological Science 1990; 95: 119–139
   PubMed Web of Science ®Google Scholar
• Ball M, Braak H, Coleman P, et al. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiology of Aging 1997; 18: 51–52, ((Suppl. 4)
   Web of Science ®Google Scholar
• Benjamin R, Leake A, Edwardson J A, McKeith I G, Ince P G, Perry R H, Morris C M. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994; 343: 1565
   PubMed Web of Science ®Google Scholar
• Samuel W, Alford M, Hofstetter C R, Hansen L. Dementia with Lewy bodies versus pure Alzheimer's disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. Journal of Neuropathology and Experimental Neurology 1997; 56: 499–508
   PubMed Web of Science ®Google Scholar
• Perry E K, Marshall E, Kerwin J, Smith C J, Jabeen S, Cheng A V, Perry R H. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry 1990; 55: 1454–1456
   PubMed Web of Science ®Google Scholar
• Byrne E J, Lennox G, Lowe J, Godwin-Austen R B. Diffuse Lewy body disease: clinical features in 15 cases. Journal of Neurology, Neurosurgery and Psychiatry 1989; 52: 709–717
   PubMed Web of Science ®Google Scholar
• McKeith I G, Perry R H, Fairbairn A F, Jabeen S, Perry E K. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine 1992; 22: 911–922
   PubMed Web of Science ®Google Scholar
• McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. British Medical Journal 1992; 305: 673–678
   PubMed Web of Science ®Google Scholar
• Förstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. British Journal of Psychiatry 1993; 162: 385–392
   PubMed Web of Science ®Google Scholar
• Salmon D P, Galasko D, Hansen L A, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition 1996; 31: 166–175
   PubMed Web of Science ®Google Scholar
• Weiner M F, Risser R C, Cullum C M, et al. Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. American Journal of Psychiatry 1996; 153: 1269–1273
   PubMed Web of Science ®Google Scholar
• Klatka L A, Louis E D, Schiffer R B. Psychiatric features in diffuse Lewy body disease: findings in 28 pathologically diagnosed cases. Neurology 1996; 46: A180
   Web of Science ®Google Scholar
• Hely M A, Reid W GJ, Halliday G M, et al. Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1996; 60: 531–538
   PubMed Web of Science ®Google Scholar
• Ala T A, Yang K-H, Sung J H, Frey W HI. Hallucinations and signs of Parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1997; 62: 16–21
   PubMed Web of Science ®Google Scholar
• Mega M S, Masterman D L, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996; 47: 1403–1409
   PubMed Web of Science ®Google Scholar
• McKeith I G, Fairbairn A F, Bothwell R A, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994; 44: 872–877
   PubMed Web of Science ®Google Scholar
• McKeith I G, Perry E K, Perry R H. Report of the second dementia with Lewy body internation workshop. Diagnosis and treatment. Neurology, (in press)
   Google Scholar
• Perry R H, Jaros E, Ince P, et al. Dementia with Lewy bodies; histopathological aspects of differential diagnosis. Neurobiology of Aging 1998; 4S: S203
   Google Scholar
• Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry 1999; 174: 45–51
   PubMed Web of Science ®Google Scholar
• McKeith I G, Fairbairn A F, Perry R H, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). British Journal of Psychiatry 1994; 164: 324–332
   Web of Science ®Google Scholar
• Forstl H, Burns A, Luthert P, et al. The Lewy body variant of Alzheimer's disease: clinical and pathological findings. British Journal of Psychiatry 1993; 162: 385–392
   PubMed Web of Science ®Google Scholar
• Harvey G T, O'Brien J T, Hughes J, et al. Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease. Psychological Medicine 1999; 29: 181–187
   PubMed Web of Science ®Google Scholar
• Barber R, Gholkar A, Ballard C, et al. Temporal lobe atrophy on MRI in dementia with Lewy bodies: a comparison with Alzheimer's disease, vascular dementia and normal ageing. Neurology 1999; 52: 1153–1158
   PubMed Web of Science ®Google Scholar
• Barber R, Gholkar A, Ballard C, et al. White matter lesions on MRI in dementia with Lewy bodies, Alzheimer's disease, Vascular dementia and normal ageing. Journal of Neurology, Neurosurgery and Psychiatry 1999; 67: 66–93
   PubMed Web of Science ®Google Scholar
• Jobst K A, Barnetson L PD, Shepstone B J. Accurate prediction of confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM IIIR criteria, SPET, X-ray CT and ApoE4 in medial temporal lobe dementias. International Psychogeriatrics 1998; 10: 271–302
   PubMedGoogle Scholar
• Jack C R, Jr, Petersen R C, O'Brien P C, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42: 183–188
   PubMed Web of Science ®Google Scholar
• O'Brien J T, Desmond P, Ames D, Schweitzer I, Chiu E, Tress B. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychological Medicine 1997; 27: 1267–1275
   PubMed Web of Science ®Google Scholar
• Robles A, Rodriguez R M, Aldrey J M, et al. Diagnostico clinico de la demencia asociada a cuerpos de Lewy corticales. Review Neurology (Bare) 1995; 23: 62–66
   PubMedGoogle Scholar
• Hashimoto M, Kitagaki H, Imamura T, et al. Medical temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998; 51: 357–362
   PubMed Web of Science ®Google Scholar
• Fox M C, Freeborough P A, Rossor M N. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996; 348: 94–97
   PubMed Web of Science ®Google Scholar
• O'Brien J T, Eagger S, Syed G S, Sahakian B J, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 1182–1187
   PubMed Web of Science ®Google Scholar
• Neary D JS, Snowden R A, Shields A W, et al. Single photon emission tomography using 99mTc-HM PAO in the investigation of dementia. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50: 101–109
   Web of Science ®Google Scholar
• Read S L, Miller B L, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia. Clinical and pathological correlation. Journal of the American Geriatric Society 1995; 43: 1243–1247
   PubMed Web of Science ®Google Scholar
• Pizzolato G, Dam M, Borsato N, et al. [99mTc] HM-PAO SPECT in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 1988; 8: S101–S108
   PubMed Web of Science ®Google Scholar
• Habert M O, Spampinato U, Mas J L, et al. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. European Journal of Nuclear Medicine 1991; 18: 3–11
   PubMedGoogle Scholar
• Donnemiller E, Heilmann J, Wenning G K, et al. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 1231-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. European Journal of Nuclear Medicine 1997; 24: 320–325
   PubMedGoogle Scholar
• Walker Z, Costa D C, Janssen A G, Walker R W, Livingstone G, Katona C L. Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine 1997; 24: 609–614
   PubMedGoogle Scholar
• Kuhl D E, Minoshima S, Fessler J A, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology 1996; 40: 399–410
   PubMed Web of Science ®Google Scholar
• Papka M, Rubio A, Schiffer R B. A review of Lewy body disease, an emerging concept of cortical dementia. Journal of Neuropsychiatry and Clinical Neurosciences 1998; 10: 267–279
   PubMed Web of Science ®Google Scholar
• Levy R, Eagger S, Griffiths M, et al. Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 1994; 343: 176
   PubMed Web of Science ®Google Scholar
• Wilcock G K, Scott M I. Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet 1994; 344: 544
   PubMed Web of Science ®Google Scholar
• Shea C, Macknight C, Rockwood R. Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. International Psychogeriatrics 1998; 10: 229–239
   PubMedGoogle Scholar
• Harrison R H, McKeith I G. Senile dementia of Lewy body type-a review of clinical and pathological features: implications for treatment. International Journal of Geriatric Psychiatry 1995; 10: 919–926
   Web of Science ®Google Scholar